Gabapentin Capsule
Product Images NDC 0904-6666

9 FDA label images from Major Pharmaceuticals · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 0904-6666). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Major Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Gabapentin-equation (Gabapentin Equation)

Gabapentin-equation (Gabapentin Equation)
A text panel displaying a formula for calculating creatinine clearance (CLCr). The formula uses variables for age in years, weight in kilograms, serum creatinine in mg/dL, and includes a multiplication factor of 0.85 for female patients.*
FDA Label Image

Structure (Gabapentin Fig 5)

Structure (Gabapentin Fig 5)
Chemical structure of the active ingredient Gabapentin. It depicts a cyclohexane ring attached to a central carbon atom bonded to an amino group (CH2NH2) and a carboxyl group (CH2CO2H).*
FDA Label Image

Gabapentin-fig1 (Gabapentin Fig1)

Gabapentin-fig1 (Gabapentin Fig1)
A line chart depicting mean pain scores over an 8-week period comparing placebo and gabapentin 3600 mg/day. The x-axis represents weeks, divided into a 4-week dose titration period followed by a 4-week fixed dose period, while the y-axis shows mean pain scores from 0 to 10. Gabapentin scores decrease steadily over time, whereas placebo scores remain relatively stable.*
FDA Label Image

Gabapentin-fig2 (Gabapentin Fig2)

Gabapentin-fig2 (Gabapentin Fig2)
A line chart showing mean pain scores over a 7-week period comparing placebo with gabapentin at 1800 mg/day and 2400 mg/day. The x-axis represents weeks, including a 3-week dose titration period followed by a 4-week fixed dose period. The y-axis measures mean pain score from 0 to 10. Gabapentin groups demonstrate a decrease in mean pain scores over time compared to placebo.*
FDA Label Image

Gabapentin-fig3 (Gabapentin Fig3)

Gabapentin-fig3 (Gabapentin Fig3)
A bar chart titled 'Proportion of Responders (patients with ≥50% reduction in pain score) at Endpoint: Controlled PHN Studies' showing data from two studies. Study 1 compares placebo (12%) with Gabapentin 3600 mg (29%). Study 2 compares placebo (14%) with Gabapentin 1800 mg (32%) and Gabapentin 2400 mg (34%). Statistical significance is noted with p-values below 0.01 and 0.001 for treatment groups.*
FDA Label Image

Gabapentin-fig4.jpg (Gabapentin Fig4)

Gabapentin-fig4.jpg (Gabapentin Fig4)
A scatter plot chart showing percentage difference on the y-axis and daily dose in milligrams on the x-axis. The chart compares data points from three studies labeled a, b, and c, with study a represented by black squares, study b by gray squares, and study c by white squares. The data points illustrate variability in percentage difference across daily doses ranging from approximately 600 mg to 1800 mg.*
FDA Label Image

100mg Carton Label (F1432ab9 9c63 4880 8c9b B851c16dc765 02)

100mg Carton Label (F1432ab9 9c63 4880 8c9b B851c16dc765 02)
Gabapentin Capsules USP 100 mg oral unit dose packaging label by Major Pharmaceuticals. The label shows 100 capsules (10 x 10) with instructions to dispense with medication guide. Storage instructions are between 20° to 25°C. The label states it is for Rx use only and not child resistant, intended for institutional use.*
FDA Label Image

300mg Carton Label (F1432ab9 9c63 4880 8c9b B851c16dc765 01)

300mg Carton Label (F1432ab9 9c63 4880 8c9b B851c16dc765 01)
Gabapentin 300 mg capsules, USP unit dose packaging label from Major Pharmaceuticals. The label shows the proprietary name Gabapentin, dosage strength 300 mg, quantity of 100 capsules (10 x 10) with an oral capsule dosage form. It includes pharmacy dispensing instructions, storage information, and a barcode. Labeler information is Major Pharmaceuticals, Indianapolis, IN.*
FDA Label Image

400mg Carton Label (F1432ab9 9c63 4880 8c9b B851c16dc765 00)

400mg Carton Label (F1432ab9 9c63 4880 8c9b B851c16dc765 00)
Gabapentin 400 mg capsules, USP label for unit dose packaging by Major Pharmaceuticals. The label includes NDC 0904-6667-61, indicates 100 capsules (10 x 10), and states that each capsule contains 400 mg of Gabapentin. It includes instructions to dispense with medication guide, storage temperature, and safety warnings. The label also shows packaging and distributor information for Major Pharmaceuticals, Indianapolis, IN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.